H2S signals through protein S-sulfhydration - PubMed (original) (raw)
H2S signals through protein S-sulfhydration
Asif K Mustafa et al. Sci Signal. 2009.
Abstract
Hydrogen sulfide (H2S), a messenger molecule generated by cystathionine gamma-lyase, acts as a physiologic vasorelaxant. Mechanisms whereby H2S signals have been elusive. We now show that H2S physiologically modifies cysteines in a large number of proteins by S-sulfhydration. About 10 to 25% of many liver proteins, including actin, tubulin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), are sulfhydrated under physiological conditions. Sulfhydration augments GAPDH activity and enhances actin polymerization. Sulfhydration thus appears to be a physiologic posttranslational modification for proteins.
Figures
Fig. 1
H2S covalently modifies proteins through S-sulfhydration of cysteine residues. (A) Liver lysates treated with 100 μM NaHS for 30 min at 37°C and subjected to the modified biotin switch assay with antibody against biotin (Anti-biotin Ab) to detect S-sulfhydration show numerous sulfhydrated proteins. (B) LC-MS/MS of a subset of the sulfhydrated proteins in (A) identifies 39 sulfhydrated proteins, including GAPDH, β-tubulin, and actin. (C) DTT treatment (1 mM) for 10 min reverses GAPDH, β-tubulin, and actin sulfhydration, detected with antibodies specific to each protein, implying a covalent sulfhydryl modification. (D) In HEK293 cells transfected with plasmids encoding CSE, exposure to 5 mM L-cysteine for 1 hour leads to GAPDH, β-tubulin, and actin sulfhydration, as assessed by the modified biotin switch assay with antibodies specific to each of the three proteins. Catalytically inactive CSE fails to sulfhydrate proteins.
Fig. 2
Sulfhydration is a physiologic posttranslational modification absent in _CSE_−/− animals. (A) Measurements of H2S production with an H2S-selective electrode indicate that _CSE_−/− liver cannot generate H2S. All results are presented as the mean ± SEM. ***P < 0.001. (B) Modified biotin switch assay in liver shows the presence of endogenous physiologic sulfhydration of GAPDH, β-tubulin, and actin in wild-type but not _CSE_−/− animals. (C) Densitometric analysis quantitating basal protein sulfhydration in liver. Data are the mean ± SEM for five to seven independent experiments with representative data shown in (B) and (D). (D) Modified biotin switch assay in liver lysates incubated with increasing exogenous doses of the CSE substrate L-cysteine for 30 min at 37°C shows a dose-dependent increase in sulfhydration in wild-type but not _CSE_−/− animals. The untreated lanes represent endogenous liver sulfhydration, showing a substantially larger signal for GAPDH than for β-tubulin or actin, consistent with the mean values depicted in (C). (E) Densitometric analysis of (D) quantitating changes in GAPDH sulfhydration with increasing exogenous doses of L-cysteine. Data are the mean ± SEM for five to seven independent experiments.
Fig. 3
Sulfhydration of GAPDH occurs at Cys150. (A) HPLC followed by LC-MS/MS on endogenous full-length GAPDH protein immunoprecipitated from mouse liver shows sulfhydration of Cys150 with an additional mass of ~32.058 daltons. m/z is the mass-to-charge ratio; the amino acid sequence surrounding Cys150 is shown at the bottom. (B) LC-MS/MS on purified full-length human GAPDH protein treated with 100 μM NaHS for 30 min at 37°C shows a mass shift consistent with Cys150 (152 in human) sulfhydration. Sulfhydration or sulfination could not be detected after treatment with 100 μM NaHS and 1 mM DTT or 500 μM H2O2, respectively. (C) Modified biotin switch assay in HEK293 cells treated with 100 μM NaHS for 30 min at 37°C. C150S mutant is not sulfhydrated. (D) Sulfhydration of GAPDH with radiolabeled [35S]cysteine and CSE at 37°C. GAPDH radiolabeling is reversed by the addition of 1 mM DTT or boiling of the CSE protein for 5 min. Data were quantified by Cherenkov scintillation counting. All results are the mean ± SEM. **P < 0.01. (E) Radiolabeling wild-type and C150S GAPDH with [35S]cysteine and CSE. C150S mutant is not labeled. All results are the mean ± SEM. ** P < 0.01.
Fig. 4
Sulfhydration physiologically increases the catalytic activity of GAPDH. (A) GAPDH activity assayed in vitro at 37°C with increasing concentrations of NaHS. NaHS dose-dependently activates GAPDH. (B) DTT (1 mM) reverses in vitro GAPDH activation by 10 μM NaHS. All results are the mean ± SEM. **P < 0.01. (C) Wild-type versus C150S mutant GAPDH activity assayed in vitro with 15 μM NaHS. Wild-type (wt) but not C150S GAPDH is activated by NaHS. All results are the mean ± SEM. **P < 0.01. (D) GAPDH activity with increasing substrate G3P concentration with or without 10 μM NaHS. NaHS increases overall _V_max without affecting Km (~0.8 mM). (E) GAPDH activity in HEK293 cells transfected with nothing or plasmids encoding wild-type CSE or catalytically inactive CSE and incubated with increasing concentrations of L-cysteine in the media for 1 hour at 37°C. GAPDH is activated in a dose-dependent manner in the presence of wild-type CSE. (F) In vivo GAPDH activity from wild-type versus _CSE_−/− liver. Livers from _CSE_−/− mice show decreased GAPDH activity (n = 6 animals). All results are the mean ± SEM. *P < 0.05.
Fig. 5
Sulfhydration enhances actin polymerization in vitro and in HEK293 cells. (A) Actin is sulfhydrated in vitro with 200 μM NaHS for 30 min at 37°C, an effect reversed by DTT (200 μM for 10 min). (B) NaHS (100 μM for 30 min at 37°C) sulfhydrates actin in HEK293 cells. (C) Immunocytochemical analysis of HEK293 cells treated with 100 μM NaHS for 1 hour at 37°C reveals rearrangement of the actin cytoskeleton (arrows show the extension of thin processes containing actin filaments in individual NaHS treated cells). Actin is stained in red. Scale bars, 20 μm. (D) NaHS (200 μM) enhances actin polymerization in vitro, an effect reversed by DTT (200 μM). (E) NaHS (200 μM) has no effect on actin depolymerization.
Similar articles
- Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is inactivated by S-sulfuration in vitro.
Jarosz AP, Wei W, Gauld JW, Auld J, Özcan F, Aslan M, Mutus B. Jarosz AP, et al. Free Radic Biol Med. 2015 Dec;89:512-21. doi: 10.1016/j.freeradbiomed.2015.09.007. Epub 2015 Nov 4. Free Radic Biol Med. 2015. PMID: 26453916 - S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics.
Módis K, Ju Y, Ahmad A, Untereiner AA, Altaany Z, Wu L, Szabo C, Wang R. Módis K, et al. Pharmacol Res. 2016 Nov;113(Pt A):116-124. doi: 10.1016/j.phrs.2016.08.023. Epub 2016 Aug 20. Pharmacol Res. 2016. PMID: 27553984 Free PMC article. - Hydrogen Sulfide Disturbs Actin Polymerization via _S_-Sulfhydration Resulting in Stunted Root Hair Growth.
Li J, Chen S, Wang X, Shi C, Liu H, Yang J, Shi W, Guo J, Jia H. Li J, et al. Plant Physiol. 2018 Oct;178(2):936-949. doi: 10.1104/pp.18.00838. Epub 2018 Aug 30. Plant Physiol. 2018. PMID: 30166418 Free PMC article. - Persulfidation (S-sulfhydration) and H2S.
Filipovic MR. Filipovic MR. Handb Exp Pharmacol. 2015;230:29-59. doi: 10.1007/978-3-319-18144-8_2. Handb Exp Pharmacol. 2015. PMID: 26162828 Review. - S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO.
Lu C, Kavalier A, Lukyanov E, Gross SS. Lu C, et al. Methods. 2013 Aug 1;62(2):177-81. doi: 10.1016/j.ymeth.2013.05.020. Epub 2013 Jun 27. Methods. 2013. PMID: 23811297 Free PMC article. Review.
Cited by
- Hypoxic regulation of the cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide pathway.
Morikawa T, Kajimura M, Nakamura T, Hishiki T, Nakanishi T, Yukutake Y, Nagahata Y, Ishikawa M, Hattori K, Takenouchi T, Takahashi T, Ishii I, Matsubara K, Kabe Y, Uchiyama S, Nagata E, Gadalla MM, Snyder SH, Suematsu M. Morikawa T, et al. Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1293-8. doi: 10.1073/pnas.1119658109. Epub 2012 Jan 9. Proc Natl Acad Sci U S A. 2012. PMID: 22232681 Free PMC article. - Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation.
Xie L, Gu Y, Wen M, Zhao S, Wang W, Ma Y, Meng G, Han Y, Wang Y, Liu G, Moore PK, Wang X, Wang H, Zhang Z, Yu Y, Ferro A, Huang Z, Ji Y. Xie L, et al. Diabetes. 2016 Oct;65(10):3171-84. doi: 10.2337/db16-0020. Epub 2016 Jun 22. Diabetes. 2016. PMID: 27335232 Free PMC article. - Fate of intracellular H2S/HS- and metallo-proteins.
Haouzi P, Klingerman CM. Haouzi P, et al. Respir Physiol Neurobiol. 2013 Aug 15;188(2):229-30. doi: 10.1016/j.resp.2013.05.029. Epub 2013 Jun 6. Respir Physiol Neurobiol. 2013. PMID: 23748103 Free PMC article. No abstract available. - The redox biochemistry of protein sulfenylation and sulfinylation.
Lo Conte M, Carroll KS. Lo Conte M, et al. J Biol Chem. 2013 Sep 13;288(37):26480-8. doi: 10.1074/jbc.R113.467738. Epub 2013 Jul 16. J Biol Chem. 2013. PMID: 23861405 Free PMC article. Review. - "Zipped Synthesis" by Cross-Metathesis Provides a Cystathionine β-Synthase Inhibitor that Attenuates Cellular H2S Levels and Reduces Neuronal Infarction in a Rat Ischemic Stroke Model.
McCune CD, Chan SJ, Beio ML, Shen W, Chung WJ, Szczesniak LM, Chai C, Koh SQ, Wong PT, Berkowitz DB. McCune CD, et al. ACS Cent Sci. 2016 Apr 27;2(4):242-52. doi: 10.1021/acscentsci.6b00019. Epub 2016 Mar 9. ACS Cent Sci. 2016. PMID: 27163055 Free PMC article.
References
- Boehning D, Snyder SH. Novel neural modulators. Annu Rev Neurosci. 2003;26:105–131. - PubMed
- Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation–like state in mice. Science. 2005;308:518. - PubMed
- Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007;6:917–935. - PubMed
- Li L, Moore PK. Putative biological roles of hydrogen sulfide in health and disease: A breath of not so fresh air? Trends Pharmacol Sci. 2008;29:84–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CAPMC/ CIHR/Canada
- K05 DA000074-30/DA/NIDA NIH HHS/United States
- R37 MH018501/MH/NIMH NIH HHS/United States
- K05 DA000074/DA/NIDA NIH HHS/United States
- T32GM007309/GM/NIGMS NIH HHS/United States
- T32 GM007309/GM/NIGMS NIH HHS/United States
- R01 MH018501-42/MH/NIMH NIH HHS/United States
- MH18501/MH/NIMH NIH HHS/United States
- R01 MH018501/MH/NIMH NIH HHS/United States
- F30 MH074191/MH/NIMH NIH HHS/United States
- 1 F30MH074191-01A2/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials